COVERAGE BRIEF · THE USE MATTERS
Coverage follows the reason for treatment
MYTH.Insurance either covers semaglutide or it does not.
FACT.As of September 2026, Medicare drug plans could pay for semaglutide prescribed for an approved medical use such as type 2 diabetes. By law, they did not cover it when it was used only for weight loss.
Ask two things. Which product is it? What is it meant to treat?
Product and purpose travel together
As of September 2026, Ozempic was approved for specific uses in adults with type 2 diabetes, while Wegovy carried approved uses that included long-term weight management.
Coverage questions need the product name and the reason it is prescribed. The ingredient name by itself is not enough.
Medicare has a temporary low-price program
As of September 2026, Medicare was running a temporary program called the GLP-1 Bridge. GLP-1 is the gut hormone that semaglutide copies. Its window was July 1, 2026 to December 31, 2027. Inside that window, eligible people with Medicare drug coverage could pay $50 a month for certain weight-loss medicines.
As of September 2026, that $50 did not count toward the Part D deductible, the amount you pay before your drug plan starts paying. It did not count toward the yearly limit on what you pay yourself either, and coupons could not be used on top.
The program has its own rules on who qualifies, and it must agree in advance before it pays. It is not a general change to Medicare law. Ask the doctor who prescribes, or your Medicare drug plan, whether you qualify.
A covered use is not a paid claim
As of September 2026, a medicine being allowed under Part D did not mean your plan would pay. Each plan keeps its own list of medicines it pays for, called a formulary. It can also require prior authorization, meaning the plan must agree before the pharmacy fills the prescription.
When you call your plan, ask about the exact product, what it is for, whether the plan must agree first, which pharmacies you may use and what you will pay.
ANNOTATED READING LIST
Evidence, with a note on why it belongs
- The federal law that lets drug plans leave out weight-loss medicines.This law is why Medicare drug plans can pay for semaglutide for diabetes but not for weight loss alone.
- Medicare’s temporary weight-medicine program.Medicare’s own page on the temporary program.
- Medicare program details written for doctors.It lists weight loss apart from the other medical uses, such as diabetes, that ordinary drug plans can pay for.